Nervous System Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinical and electromyographic diagnosis of CMT disease; both sexes; age between 16 and 65 years
Exclusion criteria
Exclusion criteria: Acute or chronic lung disease; cognitive or psychiatric alterations; severe or non controlled hypertension; heart failure; chronic renal disease; severe systemic disease; diabetes mellitus; pregnant women; obesity; active smokers; alcoholics; refused to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in sleep quality, evaluated by a questionnaire of at least 10% ;one hour increase in total sleep time, 15% reduction in waking time after sleep onset, evaluated by actigraphy | — |
Secondary
| Measure | Time frame |
|---|---|
| 15% improvement in pain perception, measured by a validated questionnaire done one week before and one week after the end of the intervention;15% improvement in fatigue perception, measured by a validated questionnaire done one week before and one week after the end of the intervention | — |
Countries
Brazil
Contacts
Universidade Federal de Sao Paulo